why choose us

First received: January 15, 2023

Clinical Trial: Ripretinib in Chinese Patients With Advanced GIST: a Real World Study

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Gastrointestinal Stromal Tumors

Study Type: Observational


Official Title: A Large Scale, Multicenter, Real-World Study on Patients With Advanced GIST Receiving Ripretinib

Brief Summary: to evaluate the clinical efficacy, safety and predictive factors of ripetinib in Chinese patients with advanced GIST in the real world

Read more